Related Experiment Video

Updated: Jun 3, 2025

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits
06:05

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits

Published on: July 21, 2023

474

Danaparoid-Consensus Recommendations on Its Clinical Use

Rupert M Bauersachs1,2, Edelgard Lindhoff-Last1, Robert Klamroth3

  • 1Cardioangiology Center Bethanien, Vascular Center and Coagulation Center, Im Prüfling 23, 60389 Frankfurt, Germany.

Pharmaceuticals (Basel, Switzerland)
|January 8, 2025
PubMed

Insights

Danaparoid sodium, an antithrombotic, offers safe and effective use for DVT prophylaxis and heparin-induced thrombocytopenia (HIT) treatment. This review provides expert-backed dosing recommendations for complex clinical scenarios.

Area of Science:

  • Pharmacology
  • Thrombosis Management
  • Anticoagulation Therapy

Background:

  • Danaparoid sodium is a long-standing heparinoid antithrombotic.
  • It is utilized for deep vein thrombosis (DVT) prophylaxis in non-heparin-induced thrombocytopenia (HIT) patients.
  • It also serves as a treatment for HIT, with or without thrombosis.

Purpose of the Study:

  • To update information on danaparoid sodium pharmacology.
  • To review danaparoid dose management across diverse clinical situations, including off-label uses.
  • To establish consensus on dosing regimens for complex cases and vulnerable populations.

Main Methods:

  • Analysis of published clinical studies and case reports.
  • Inclusion of data from compassionate use and adverse event reports.
  • Consensus development by an interdisciplinary expert group.

Main Results:

  • Proposed dosing regimens for danaparoid sodium.
  • Recommendations for monitoring anticoagulation.
  • Identification of target anti-factor Xa ranges for effective therapy.

Conclusions:

  • Comprehensive interdisciplinary dosing recommendations are presented.
  • These guidelines aim to ensure the safe and effective utilization of danaparoid sodium.
  • The recommendations provide a basis for managing anticoagulation in complex patient groups.

Keywords:
Orgarananticoagulantdanaparoiddosingheparin-induced thrombocytopeniaheparinoidmonitoringoff-label usethromboprophylaxisvenous thromboembolism

More Related Videos

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

408
DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.4K

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
146
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K